Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
EMA Backs Approval of Elahere for Ovarian Cancer
The European Medicines Agency (EMA) has determined that the medicinal product Elahere (mirvetuximab soravtansine, AbbVie Deutschland), indicated for the treatment of adults with folate receptor alpha (FR-alpha)–positive epithelial ovarian, fallopian tube, and primary peritoneal cancer, should be granted a marketing…
English